Protagonist Therapeutics, Inc - Common Stock (PTGX)

CUSIP: 74366E102

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock
Shares outstanding
62,457,444
Total 13F shares
37,171,432
Share change
+3,117,602
Total reported value
$727,253,818
Price per share
$19.55
Number of holders
91
Value change
+$62,067,302
Number of buys
47
Number of sells
44

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
8.3%
5,165,205
$91,217,000 30 Jun 2020
13F
RTW INVESTMENTS, LP
13F
Company
5.4%
3,383,208
$59,747,000 30 Jun 2020
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
4%
2,500,000
$44,150,000 30 Jun 2020
13F
Johnson & Johnson Innovation - JJDC, Inc.
13F
Company
3.9%
2,449,183
$43,253,000 30 Jun 2020
13F
BVF INC/IL
13F
Company
3.8%
2,367,288
$41,806,000 30 Jun 2020
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
3.5%
2,200,000
$38,852,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
3.3%
2,041,460
$36,053,000 30 Jun 2020
13F
BAKER BROS. ADVISORS LP
13F
Company
3.1%
1,911,446
$33,756,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
2.3%
1,420,361
$25,084,000 30 Jun 2020
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1.6%
1,013,495
$17,898,000 30 Jun 2020
13F
JPMORGAN CHASE & CO
13F
Company
1.3%
837,864
$14,797,000 30 Jun 2020
13F
Novo Holdings A/S
13F
Company
1.3%
824,169
$14,555,000 30 Jun 2020
13F
D. E. Shaw & Co., Inc.
13F
Company
1.3%
812,946
$14,356,000 30 Jun 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.2%
747,634
$13,203,000 30 Jun 2020
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.1%
686,897
$12,130,000 30 Jun 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.85%
532,300
$9,400,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.85%
530,048
$9,361,000 30 Jun 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.67%
419,200
$7,403,000 30 Jun 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.62%
384,205
$6,785,000 30 Jun 2020
13F
STATE STREET CORP
13F
Company
0.61%
382,894
$6,762,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.59%
368,370
$6,505,000 30 Jun 2020
13F
Sofinnova Investments, Inc.
13F
Company
0.52%
326,064
$5,758,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
0.52%
325,801
$5,754,000 30 Jun 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.46%
289,978
$5,121,000 30 Jun 2020
13F
Invesco Ltd.
13F
Company
0.38%
234,281
$4,137,000 30 Jun 2020
13F
Squarepoint Ops LLC
13F
Company
0.19%
118,120
$3,414,000 30 Jun 2020
13F
Russell Investments Group, Ltd.
13F
Company
0.29%
181,736
$3,205,000 30 Jun 2020
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.24%
150,694
$2,661,000 30 Jun 2020
13F
Artal Group S.A.
13F
Company
0.22%
140,000
$2,472,000 30 Jun 2020
13F
Bank of New York Mellon Corp
13F
Company
0.16%
101,352
$1,790,000 30 Jun 2020
13F
MARTINGALE ASSET MANAGEMENT L P
13F
Company
0.16%
97,200
$1,717,000 30 Jun 2020
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.14%
84,417
$1,491,000 30 Jun 2020
13F
Allianz Asset Management GmbH
13F
Company
0.12%
75,790
$1,338,000 30 Jun 2020
13F
UBS Group AG
13F
Company
0.11%
68,687
$1,213,000 30 Jun 2020
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.11%
68,279
$1,206,000 30 Jun 2020
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.11%
67,305
$1,188,000 30 Jun 2020
13F
CITIGROUP INC
13F
Company
0.1%
64,547
$1,140,000 30 Jun 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.09%
57,072
$1,008,000 30 Jun 2020
13F
BESSEMER GROUP INC
13F
Company
0.09%
53,500
$945,000 30 Jun 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.08%
50,000
$883,000 30 Jun 2020
13F
J. Goldman & Co LP
13F
Company
0.08%
49,359
$872,000 30 Jun 2020
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.07%
46,707
$825,000 30 Jun 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.15%
90,772
$701,000 30 Jun 2020
13F
TD ASSET MANAGEMENT INC
13F
Company
0.06%
39,353
$695,000 30 Jun 2020
13F
WINTON GROUP Ltd
13F
Company
0.06%
38,611
$682,000 30 Jun 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.05%
34,044
$601,000 30 Jun 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
29,676
$524,000 30 Jun 2020
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.05%
28,598
$505,000 30 Jun 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.04%
28,000
$494,000 30 Jun 2020
13F
FRANKLIN STREET ADVISORS INC /NC
13F
Company
0.04%
23,300
$411,000 30 Jun 2020
13F

Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q3 2020

As of 30 Sep 2020, Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,171,432 shares. The largest 10 holders included FMR LLC, RTW INVESTMENTS, LP, FARALLON CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., Johnson & Johnson Innovation - JJDC, Inc., BVF INC/IL, Consonance Capital Management LP, BAKER BROS. ADVISORS LP, and VANGUARD GROUP INC. This page lists 91 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
82
Q3 2020 holders
91
Holder diff
9
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.